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The aim of this study was to compare the two opioids methadone and 
buprenorphine in sedative combinations administered to cats undergoing 
castration in a high-volume neutering setting. Both combinations were 
used prior to orchidectomy in cats (Routine Cat Castrations) as part of a 
‘drop-in clinic’ with no prior appointments required. The overall outcome 
was to determine a combination to best enable a safe, quick, effective 
turnover of neuters with limited financial, infrastructure and staffing 
resources.  
 
A total of 166 cats were recruited as part of this clinical trial. This included 
15 cases as part of a pilot study. The aim was to gain two equal numbers 
for each group over a set period of time. Quantitative planning of the total 
study was not known as this was incorporated as part of a working 
teaching unit in conjunction with Nottingham university. The drop-in clinic 
took place every Friday which allowed an open appointment system from 
different demographics such as vet triage, owned patients, multi-cat 
household, stray and ferals as part of an TNR programme.  
 
Cats received one of two possible combinations, medetomidine 
600mcg/m² with buprenorphine 180mcg/m² (MB) or medetomidine 





Sedation was scored using a modified simple descriptive score (SDS) 10 
minutes after administering the initial injection. Anaesthesia was induced 
using isoflurane administered in 100% oxygen via a tight-fitting face 
mask connected to an Ayres T piece with Jackson Rees modification. 
Parameters were recorded at 5-minute intervals intraoperatively. At the 
end of surgery isoflurane was discontinued and one minute later 
atipamezole was administered IM. The recovery stage was monitored 
and timing to sternal recumbency followed by portal exploration were 
recorded. Data collection was recorded on anaesthetic record sheets and 
transposed to an Excel spreadsheet at a later date.  
 
The medetomidine and methadone combination had significantly higher 
sedation scores using the SDS modified system. This result included an 
element of mask induction assessment when compared to the use of the  
medetomidine and buprenorphine combination, which consistently 
scored low on the SDS system. Methadone provided superior sedation 
to buprenorphine prior to anaesthesia maintenance using mask induction 
as part of the protocol. The recovery data showed both sternal and portal 
times were significantly shorter with medetomidine and methadone 
compared to medetomidine and buprenorphine.  
 
Both combinations proved suitable for cat castration anaesthesia. Using 
the methadone combination can increase the turnover of patients 
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Overpopulation of felines in the United Kingdom (UK) poses a major 
problem for most welfare organisations. The factors are complex and 
intertwined, and specific for the owned and unowned population. 
Relinquishment places enormous demands on shelters in terms of 
economics and this in turn reduces the ability of rehoming of animals 
(Stavisky et al. 2012). Understanding the nature of these populations 
would enable resources to be targeted in the right direction thereby 
improving animal welfare. The issue of unplanned pregnancies through 
uncontrolled reproduction in the stray and unowned cats population is 
also exacerbated by issues such as lifestyles of ownership, pre-
expectations of owning a cat and lack of owner education as a strong 
factor. Statistically it has been shown that there are 7.5 million cats in the 
UK (Pet Population report 2019, Pet Food Manufacturers Association). 
There are also an estimated 23% of UK households having at least one 
cat, with some evidence indicating that up to 39% of the population may 
own more than one feline, illustrating the potential for overpopulation (Hill 
et al. 2019). Yet, quantifying the ownership of cats is complex, with 
Stravinsky et al., (2012) suggesting that it is less common for more than 
two cats to be owned (Stavisky et al. 2012). 
 
A figure of ownership which is deemed as a ‘problematic’ situation for 
welfare organisations by way of interventions, is defined as the number 
of animals exceeding the owner’s capacity for care. Some North 
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American states have even set thresholds for cat ownership which clearly 
defines excess or a given concern of hoarding (Hayes 2010). 
 
Hoarding is a huge problem for shelters due to the intermittent yet 
significant influx of animals in any given period. This creates problems 
with staffing and space management. Dealing with hoarding is complex 
in itself as a pathological accumulation of animals are not necessarily 
focused on cats as a species but could also be an accumulation of 
inanimate objects which serves to provide a level of comfort due to the 
underlying cause of trauma. Further research is needed to characterise 
the reasoning with underlying causes. Hoarding behaviour is typically 
associated with mental illness which requires managed support usually 
through a network of specialised counsellors with expertise in areas such 
as obsessive-compulsive disorders.  
 
Owners’ lack of knowledge is also a factor in feline reproduction. This 
oversight contributed to an estimated shelter intake of 130,000 to 
150,000 cats during the period of 2009 and 2010 (Welsh et al. 2014, 
Welsh 2018). More recently statistics from the R.S.P.C.A have seen 
29,432 cats brought into their shelters in 2019 alone (R.S.P.C.A, 2021).  
The constant influx of animals can have a negative impact on welfare 
within shelters as those cats kept for prolonged periods of time prior to 
rehoming are at an increased risk of psychological and physical 




Welfare organisations in the UK are now employing innovative 
approaches through education and awareness programmes to highlight 
the importance of prepubertal neutering. The traditional accepted age of 
neutering was 5 to 8 months; however, studies have shown that early 
age neutered cats (6 - 14 weeks) have lower morbidity, and there are no 
behavioural or physical differences (Roberts and Clements 2015). The 
employment of new, safe and reliable anaesthesia and surgical 
techniques means this can be performed effectively. The implications of 
prepubertal neutering for welfare charities are enormous especially when 
resources are considered, for example cost factors of anaesthetic drugs. 
In the private sector, 28% of all veterinarians are undertaking early age 
neutering so the welfare principles must continue to be reinforced as an 
advantage to promote this further (Murray and Skillings 2008, Welsh 
2018). A recent study surveying a cross section of the UK public has 
shown that more than 80% support the practice of routine neutering 
(Wongsaengchan and McKeegan 2019). It is known that the proportion 
of accidental litters is as much as 80%. This figure was reported in a 
survey from 715 cat owning households (Welsh et al. 2014). The 
informed approach to preventing accidental litters through precautions is 
effective along with veterinary neutering. Such examples are knowledge 
of puberty timings, segregation of young pubescent queens and 
prepubertal neutering.  
 
The Cat Group, which is a collective collaboration of welfare 
organisations have a policy statement, states that there is a strong case 
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for neutering earlier than the traditional age of six months on the grounds 
of social, health and population reasons (The Cat Group, 2006). In some 
cases, feral cats are being neutered as early as eight weeks. This in turn 
assists the RSPCA which is striving to reduce the acceptable age of 
neutering to 10-12 weeks and is promoting this through education 
initiatives. The cost benefit of this approach is difficult to ignore and deny. 
Equally though, it is important to promote control of unowned cats such 
as feral colonies which can pose a persistent problem.  
 
It has been suggested that euthanasia as a means of population control 
could be considered. There has been some success with a dramatic 
decline in population numbers but only on small islands (under 5km²) 
successfully, and these were inhabited by people. This is a controversial 
view and not often favoured by welfare organisations (McCarthy, Levine, 
and Reed 2013). 
 
One study evaluated three methods of feral cat population control 
(euthanasia, trap-neuter and release and trap-vasectomy-hysterectomy 
and release) (McCarthy, Levine, and Reed 2013). This study found that 
annual capture rates of above 97%, for all the methods appeared to be 
effective in reducing population sizes but lethal control was most effective 
out of the three. Trap-vasectomy-hysterectomy appeared to be effective 
at annual capture rates of between 19% and 97%. From the study it 
showed that trap, neuter and release did not outperform the other 
methods. In contrast despite the methods, it is known that lethal control 
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is unacceptable to the general public and welfare organisations are 
careful not to have this perception of an acceptable means of control. 
One of the RSPCA’s neutering campaign involves an initiative having a 
purpose-built vehicle which can perform ‘off site’ i.e. away from the 
hospital work and target specific areas of the community (Figure 1). This 
is ideal for approaching multi-cat households, a product of hoarding, 
resulting in owner’s poor compliance with their welfare requirements. 
Such circumstances are often associated with mental health illness in the 
caregivers, inevitably leading to scenarios of poor husbandry conditions 
with evidence of poor socialisation and neglect potentially requiring 
euthanasia (Polak et al. 2014, Hill et al. 2019, Jacobson et al 2020). 
 
Furthermore, confinement of cats in a rehoming facility for a significant 
period can also potentially cause stress in itself. This could pose health 
risks to staff such as human related aggression. Studies have shown that 
neutering male kittens from an early age reduced unwanted behaviours 
such as urine spraying and also aggression. Castrated males have 
shown to have a longer lifespan with 62% of neutered cats living longer 
than entire males (Wongsaengchan and McKeegan 2019). Female cats 
have been shown to have a 91% reduction in mammary carcinomas if 
spaying occurred prior to the age of 6 months (Joyce and Yates 2011). 
From a welfare perspective the duration of hospitalisation of feral animals 
undergoing neutering and treatment should be minimised, and animals 
always returned to the place of capture (Sparkes et al. 2013). This 
supports the development of suitable anaesthetic regimes in mobile 
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facilities in order to reduce time, hospitalisation and cost associated with 
neutering and improve animal welfare. 
 
To date numerous anaesthetic combinations with different analgesic 
effects and recovery profiles have been evaluated in cats. A multitude of 
studies have been undertaken evaluating alpha 2 agonist and opioids 
combinations followed by volatile agents with and without ketamine. 
Additionally, protocols incorporating propofol and alfaxalone have been 
studied. A recent refinement of a benzodiazepine added to the Triple 
combination of ketamine, alpha 2 agonist and opioid has been employed 
successfully for early neutering. These combinations are detailed below. 
(Shah et al. 2019, Polson et al. 2012, Moser et al. 2020, Mahdmina et al. 
2020). 
 
      
   






2.0 Literature review 
 
2.1 Surgical Procedures 
 
Neutering of cats is by far one of the most common surgical procedures 
undertaken in veterinary practice. Population concerns is one of the cited 
reasons for this from the profession along with welfare concerns such as 
those shared by the RSPCA. Reproductive diseases involving the 
prostate, testes, the uterus, ovaries and mammary glands can be 
reduced. Unwanted behaviours such as vocalising and roaming leading 
to feral and large colonies in stray populations are also factors to be 
considered.  
 
2.1 a. Ovariohysterectomy in the cat 
 
The ovariohysterectomy (OVH) surgery can be performed via a midline 
approach or flank approach. From a veterinary student’s perspective, the 
midline approach is preferred to the flank as this allows for better 
visualisation of the uterus and also to assist dealing with any potential 
pregnancies if necessary. In some cases, if access proves difficult, the 
incision can be extended. The definition of OVH is complete removal of 
the uterus and ovaries. It is cited that 96% of UK surgeons do in fact use 
the flank approach (Grint et al. 2006). The procedure involves locating 
the ovaries by following the uterine horns once the abdominal cavity is 
entered. Ligaments from the ovaries to the abdominal wall are ruptured. 
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The ovarian blood vessels are clamped and ligated which allows 
exteriorisation of the ovaries and uterus, which is then clamped and 
ligated above the cervix. The is followed by closure of the layers of the 
abdominal wall using appropriate suture material. 
 
2.1 b. Orchidectomy in the cat. 
 
The orchidectomy procedure is relatively quick surgery involving an 
incision of each scrotal sac through which each testicle is completely 
removed. Ductus deferens are used to tie off spermatic vessels in an 
open castration technique, this method usually involves no sutures. 
There are other techniques employed such as spermatic bundles ligated 
with suture material usually absorbable and the latter technique is the 
use of haemostats in a technique where the spermatic bundle is tied upon 
itself (Porters et al. 2014). Approximately 1% of all kittens presented 
especially in early castrations are known to be cryptorchid which 
emphasises the importance of pre-anaesthesia checks and testes 










2.2 Anaesthetic Drugs  
 
2.2 a Multimodal anaesthesia  
 
The following literature review explores the different components of 
balanced anaesthesia. From a welfare perspective for charities, it is also 
necessary to identify practicalities and consider cost as this may be 
different to the private veterinary sector.  
 
A multimodal approach describes using more than one drug, each having 
a measured mechanism of action (Corletto 2007). Balanced analgesia 
using a combination of drugs which affects nociception in different ways 
in the body is well recognised (Brown, Pavone, and Naranjo 2018). The 
theory behind the multimodal approach is to combine different 
mechanisms of action and also reduce the volume of each component, 
which is also a crucial factor in terms of cost especially from a shelter 
medicine perspective. This will reduce the incidence of side effects from 
higher doses of the individual drugs. 
 
In charity practice anaesthesia, the intramuscular (IM) route is often 
utilised and preferred. The reason for this is both ease of administration 
and there is a time factor to consider for aseptic venepuncture 
techniques. Additionally, from an early neuter perspective, venous 
access may not always be possible because of the size of the kittens. 
Given that the aim is quick turnover of neuters in a short period of time 
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especially in multi-cat household intervention programmes a quick, 
simple and easy to administer anaesthetic is paramount.  
 
The multimodal approach can also include a method of producing doses 
of equal volumes (Mahdmina et al. 2020) facilitating the procedure and 
reducing the likelihood of error.  
 
Mask induction of anaesthesia can be used as part of the multimodal 
protocol especially in a charity setting as this ensures a more rapid 
progression of induction of anaesthesia reducing overall time of 
anaesthesia. 
 
The following is an overview of each component used individually in a 




Anaesthetic protocols including alpha-2 adrenoreceptor agonists (a-2 
agonist) have frequently been used in neutering programs in shelter 
medicine. This has been documented since 1994 (Granholm et al. 2007, 
Ansah, Raekallio, and Vainio 1998, Harrison et al. 2011). 
 
Medetomidine is widely given as part of a Quad protocol which bases the 
calculation on body surface area (BSA) initially at 1000 ug/mᒾ rather than 
bodyweight. In essence, cats will tend to be given higher volumes of 
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medetomidine based on lower body mass because of the calculation of 
BSA (Joyce and Yates 2011). 
 
The Quad was developed using medetomidine, buprenorphine, 
midazolam and ketamine and it is usually prepared in four equal doses 
using the Kitten Quad calculator (Clancy 2016). 
 
The licensed dose of medetomidine for cats according to the 
manufacturer's guidelines is 50–100 ug/kg with a volume of 0.25–
0.5ml/5kg for moderate sedation and 100–150 μg/kg with a volume of 
0.5–0.75 ml/5kg for deep sedation (Dechra products). 
 
Medetomidine is a racemic mixture of two optical enantiomers, 
dexmedetomidine and medetomidine. Studies have found the L-isomer 
component of the medetomidine is inactive and has no biological activity 
although drug interaction has a role. Racemic medetomidine is lipophilic 
which offers a rapid onset of absorption after administration via the 
intramuscular route with peak plasma concentrations evident on average 
after 30 minutes (Lamont 2009). Medetomidine does negatively impact 
the regulation of body temperature which could be an issue with younger 
patients and considerations must be made to ensure assistive support is 
given (MacDonald, Scheinin, and Scheinin 1988). Medetomidine may 
also cause hyperglycaemia during anaesthesia by a reduction of insulin 
secretion (Sinclair 2003, Guedes et al. 2013). The impact of this in a short 
anaesthetic is unknown. The benefits of medetomidine are reliable 
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sedation, muscle relaxation, analgesia and also importantly it reduces 
the requirements for inhalation agents such as isoflurane (anaesthetic 
sparing) (Sinclair 2003). The reported duration of action will depend on 
other components such as the opioid. Studies have shown that the 
duration of antinociception of medetomidine with buprenorphine is 6–8 
hours; when combined with methadone this is shorter at 4–6 hours and 
lastly the use of butorphanol combined with medetomidine provided 2 
hours antinociception (Slingsby, Bortolami, and Murrell 2015). 
 
There have been some studies which have suggested that 
dexmedetomidine offers marginally superior analgesia compared to 
those using medetomidine (Bruniges, Taylor, and Yates 2016). Recent 
studies comparing dexmedetomidine and medetomidine have included 
antinociceptive effect assessment whereas previously behavioural 
assessment models were used. Further work in this area is required.  
 
One key advantage of alpha-2 agonists is the ability to antagonise the 
drugs with an alpha-2 antagonist such as atipamezole. The recovery 
from medetomidine is commonly associated with ataxia which 
atipamezole minimises through shortening the duration of recovery or 
even to the point of eliminating the effects of medetomidine sedation (El-
Kammar and Gad 2014). The alpha-2 antagonist can also be used if 
adverse reactions occur or if poor anaesthesia and / or recovery is 
evident. Antagonism often utilises a dose of atipamezole equivalent to 
half the initial medetomidine dose. However, this can cause adverse 
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reactions which are often reported as vomiting and diarrhoea 
(DeClementi 2007). The effects of atipamezole on sedation versus 





Ketamine use is commonplace in veterinary anaesthesia. Ketamine is a 
dissociative anaesthetic and has antinociceptive properties. A 
dissociative (cataleptic) state is characterised by increased muscle tone, 
and unconsciousness. Some physical signs such as excessive eye 
movements (nystagmus), limb movements and open eyes are also 
evident which can be counteracted with a combination of additional 
drugs. Ketamine has a wide safety margin and is a component of many 
multimodal protocols.      
 
Ketamine is rarely used as a sole agent due to the poor anaesthesia and 
muscle rigidity hence the use of other drugs as part of a combination to 
offset these undesirable effects (Glen 1973). Respiration and 
cardiovascular systems are only depressed when ketamine is used in 
high doses (Giroux et al. 2015). However, in one study using 
medetomidine administered with ketamine, 80% were reported to have 
developed a decreased rate of respiration and apnoea due to 
vasoconstriction (Verstegen, Fargetton, and Ectors 1989). Ketamine can 
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be administered either IM or intravenously (IV) although it is most 
commonly given via the IM route for ease of administration. 
 
Ketamine is particularly useful in feral cat management because these 
animals cannot be handled easily. Feral cats are often an unknown 
weight, age and health status. This requires anaesthesia with a wide 
safety margin, providing a quick recovery, so that the cats can be 
returned to their natural environment optimising their welfare (Harrison et 
al. 2011). 
 
Ketamine can also be used to improve the plane of anaesthesia in 
lengthy procedures, such as ovariohysterectomy in pregnant feline 
patients or those requiring additional diagnostic or surgical procedures 
(Harrison et al. 2011). 
 
Early studies using ketamine as part of a protocol, such as medetomidine 
(80μg/kg) with ketamine 10mg/kg, showed no reflex responses when the 
ovarian ligament / pedicle was ligated during surgery (Verstegen et al. 
1989). In a similar study using the same combination but lower doses of 
ketamine at 5 and 7.5mg/kg respectively, there were no differences to 
heart rates during the same type of surgery (Verstegen et al. 1991). This 
shows the potential of varying doses of ketamine but with the same 
outcomes. Further research exploring thresholds of ketamine and its 




The administration of drugs via the IM route is occasionally likely to result 
in incomplete intramuscular delivery, most likely when inexperienced 
surgeons or veterinary students inject the drugs. In one study it was 
shown that 11% of cats required supplemental anaesthesia with 
isoflurane (Harrison et al. 2011). The duration of procedures such as 
castrations versus ovariohysterectomy could see a variation in the use of 
supplementary anaesthesia but this is dependent on the success of the 




Atipamezole is a potent highly selective alpha-2 antagonist with a rapid 
onset of action. Atipamezole is used to reverse, or more correctly, 
antagonise the effects of medetomidine and is often referred to as the 
reversal agent (Baldwin et al. 2008). 
 
The recommended dosage for atipamezole is 0.04 ml/kg (200 μg/kg body 
weight) using a 5mg/ml formulation (Bruniges, Taylor, and Yates 2016). 
It is known that the effects of antagonism are reflected in the dose of 
medetomidine and the time of administration and dose of atipamezole 
(El-Kammar and Gad 2014). 
 
The action of atipamezole antagonises the peripheral and central effects 
of alpha 2 agonists. There have been numerous studies which have 
researched the effects of atipamezole dose in relation to the length of 
16 
 
time of recovery (Bruniges, Taylor, and Yates 2016, Warne et al 2016). 
In this study, atipamezole was administered after 40 minutes as part of a 
multimodal approach using the Quad. The result showed this significantly 
reduced the recovery time by as much as 1 hour compared to those not 
using atipamezole (Bruniges, Taylor, and Yates 2016). The 
recommendation therefore is the administration of atipamezole after 40 
minutes, so the ketamine component has ceased, and this promotes a 
smooth recovery. There were faster recoveries in patients that were 
under 6 months old compared to adults. This same study stated that the 
use of the dexmedetomidine as part of the Quad had a reduced recovery 
time by 10 minutes with atipamezole compared to 19 minutes without the 
use of atipamezole (Bruniges, Taylor, and Yates 2016). There were no 
differences in recovery time between groups given dexmedetomidine 
and medetomidine, where both groups were antagonised with 
atipamezole. 
 
Atipamezole should be considered in early neutering protocols. The 
respiratory depression can become significant when medetomidine is 
combined with other injectable agents. The cardiovascular effects such 
as bradycardia and reduced cardiac output can have more significant 
consequences in a paediatric or young patient compared to an adult 






2.3 Opioids  
 
2.3.a Methadone  
 
The use of methadone as an analgesic for feline neutering in the UK is 
on the increase. A recent survey showed that this was the result of 
greater awareness, increased licensed availability and the improved 
knowledge of addressing pain management (Hunt et al. 2015). 
 
The dose range is 0.3-0.6mg/kg for feline patients in the UK and the 
European countries (Bortolami and Love 2015). Methadone is a pure μ 
synthetic opioid receptor agonist. The methadone used in the UK is 
licensed as a racemic mixture formed of two isomers. The analgesic 
effect is obtained when the L-isomer binds to the μ receptor. Prevention 
of central sensitisation and hyperalgesia is due to the D-isomer which is 
defined as non-competitive N-methyl D-aspartate (NMDA) antagonist 
(Shah et al. 2018). Methadone also inhibits serotonin and noradrenaline 
in the descending pain pathways (Codd et al. 1995). 
 
Full μ opioids agonist such as methadone are easily titrated to effect 
which offers the ability to adjust dosage in specific scenarios especially 
in challenging cases.  
 
Methadone could be used as part of a multimodal regime and combined 
with other drugs such as alpha-2 agonists or it could be administered with 
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a sole analgesic. It is used as an effective approach in management of 
acute pain and has a wide therapeutic margin and the effects can be 
antagonised if needed.  
 
There were concerns over excitatory effects historically although at 
clinical doses this is minimal. Mydriasis does persist for longer than 
analgesia which could potentially affect vision in the short term (Bortolami 
and Love 2015). 
 
Methadone has been documented to reduce the minimum alveolar 
concentration (MAC) of sevoflurane in feline patients as much as 25% so 
this highlights the care needed when using opioids. It is important to note 
that MAC reduction is not a substitute for analgesia as pain is associated 
with supraspinal pathways rather than at the spinal cord level which only 
measures the potency of the inhalation anaesthetic. The use of a potent 
opioid such as methadone offers the advantage of less inhalation 
anaesthetic use in cats hence reduction in costs.  
 
The combination of methadone (0.5mg/kg) and medetomidine 
(0.02mg/kg) as a premedicant for ovariohysterectomy and castration 
showed satisfactory analgesia for 6 hours post administration (Slingsby, 
Bortolami, and Murrell 2015, Bortolami and Love 2015). In one 
experimental model methadone offered superior analgesia when 




The use of IV methadone (administered slowly) in both dogs and cats 
has been reported to have no adverse cardiovascular effects and 
respiratory efforts have been documented as minimal. Bradycardia and 
reduced respiratory rates are reported when methadone is given to 




Buprenorphine was developed in the 1970s and has been a crucial 
aspect of management of pain in cats (Steagall, Monteiro-Steagall, and 
Taylor 2014). Buprenorphine can be used as the opioid component of 
the Quad protocol. This is a popular combination offering a good 
balanced approach. Buprenorphine is typically preferred over 
butorphanol due to the longevity and potency of postoperative analgesia 
(6–12 hours compared with 1–2 hours) (Joyce and Yates 2011). 
Buprenorphine has a delayed onset but is also long acting with moderate 
analgesia and few adverse effects (Lizasoain, Leza, and Lorenzo 1991). 
 
Buprenorphine is a potent highly lipophilic semi synthetic partial μ agonist 
opioid, a derivative of thebaine. It has been documented that 
buprenorphine could be considered as kappa (κ) antagonist or μ receptor 
antagonist at high doses (Pergolizzi et al. 2010). In some species 
studies, it is classified as a full μ agonist (Steagall, Monteiro-Steagall, 
and Taylor 2014). Buprenorphine has market authorisation in cats in the 
USA and most European countries.  
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There are wide variations in the analgesic effects, and this is associated 
with different routes of administration, doses and obviously the variation 
of different cats presented. Buprenorphine doses of 0.02mg/kg and 
0.04mg/kg has been reported to offer a greater degree of mechanical 
antinociception than that seen with 0.01mg/kg (Steagall, Monteiro-
Steagall, and Taylor 2014). 
 
Buprenorphine is very versatile and can be administered IV, IM, 
subcutaneously (SC), transdermally and via the oral transmucosal route 
(OTM) (Bortolami and Love 2015). Studies have shown that 
buprenorphine is an effective analgesic in cats undergoing a variety of 
procedures, and this has been widely documented especially with 
ovariohysterectomy and even with complex orthopaedic work 
(Mollenhoff, Nolte, and Kramer 2005). In one study, the analgesic 
properties and recovery effects of two doses 0.12mg/kg and 0.24mg/kg 
of subcutaneous buprenorphine were compared in cats undergoing 
ovariohysterectomy. This research showed that 0.12mg/kg provided 
adequate analgesia as part of a multimodal approach. The higher dose 
buprenorphine in this study was well tolerated and this dose may allow 
an increase in the interval between doses which is currently advised at 
6–8 hours frequency without loss of analgesia with reduced adverse 
effects (Leedham et al. 2019).  
 
Early studies evaluating antinociception did in fact demonstrate a bell-
shaped dose dependent curve where higher doses led to decreased 
21 
 
effect or no analgesia produced and in some studies a ceiling effect. This 
finding has led to further studies into this phenomenon (Slingsby, Taylor, 
and Murrell 2011). 
 
The thermal effects of buprenorphine are also crucial, as research has 
suggested that the use of buprenorphine produced a mild to moderate 
elevation of body temperature (Posner et al. 2010). This effect could 
reduce the need for additional warming of the patient in the postoperative 
period. Hypothermia is often a factor to consider with early neutering 
hence that could pose a valuable contribution to any multimodal regime 
in addition to the analgesic effects (Joyce and Yates 2011, Posner et al. 
2010). 
 
2.4 Anaesthesia combinations  
 
The Quad protocol was originally devised in early 2000 in response to 
inadequate licensed IM protocols at the time. The difficulties seen initially 
were primarily due to reliable depths or planes of anaesthesia, 
particularly in patients with lower body mass i.e., less than 1.5kg. The 
calculation of the Quad protocol was modified to consider a greater body 
surface area (BSA) to mass ratio (Joyce and Yates 2011). The formula 
used is BSA = K x (body weight), this is where K is a shape constant. 
This is documented in a study evaluating a formula to improve dosing for 
chemotherapeutic agents in ferrets by Jones et al, (2015). It does state 
that the value of K differs amongst species which clearly shows that a 
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Quad protocol such as this would be unsuitable for a ferret for example. 
One of the problems of estimating BSA is that this increases the risk of 
under dosing hence the inefficiency of sedation and potentially adverse 
effects (Jones et al. 2015). 
 
Previous studies using Quad combinations have shown sufficient 
analgesia for the younger feline patients, lower mortality rates and rapid 
recoveries (Polson, Taylor, and Yates 2012). 
 
The Quad protocol includes medetomidine which is calculated at BSA 
(this would be a higher dose if a patient had a lower BSA) and midazolam 
to provide sedation and muscle relaxation and an indirect way of 
reducing the medetomidine dose. Buprenorphine is included as the 
opioid analgesic plus it causes a slight increase in body temperature 
which is of benefit postoperatively. The last component of the Quad is 
ketamine, a dissociative anaesthetic and analgesic, the side effects 
which is offset by the midazolam and alpha 2 agonist. The Quad protocol 
offers a simple approach to calculations based on accurate weight and 
results in four equal doses of the individual components. 
 
The Triple combination was formulated in the 1990s and consisted of 
medetomidine, butorphanol and ketamine.  The principle aim of the Triple 
at that time was to offer reliability, a smooth recovery and incorporate 
muscle relaxation to offset the effects of ketamine (Ko et al. 2011). In 
some cases, butorphanol rather than buprenorphine has been used as 
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part of the ‘Triple combination’ although this would have a shorter 
duration of analgesia of 2 hours. Atipamezole may be given to the patient 
to reduce the recovery time without adversely affecting the analgesic 
properties which the Triple offers (Ko et al. 2011).  
 
In dogs the combination of medetomidine with butorphanol produces a 
profound sedation apparent after 20 minutes of administration based on 
a dose of 25 μg/kg medetomidine and 0.1mg/kg butorphanol. Dogs are 
given ketamine (5mg/kg) separately to medetomidine and butorphanol 
and this will facilitate minor procedures (Yates 2018). In cats, the Triple 
is given as a single dose of 0.4mg/kg butorphanol, 80μg/kg 
medetomidine and 5mg/kg of ketamine. The effect is cats become 
sedated in as little as 2–3 minutes post IM injection. 
 
2.5. Inhalation Anaesthesia 
 
2.5 a, Isoflurane. 
 
Isoflurane was introduced to the UK in 1983. Trials have shown 
isoflurane to be superior to halothane and enflurane in human studies 
(Nunn 1985). Isoflurane superseded halothane in small animal practice 
in the late 1990s.  
 
Maintenance of anaesthesia with volatile inhalation agents is still 
favoured today and widely used in the veterinary industry. The reasons 
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for the ongoing popularity include qualities of being predictable and 
accurately titratable with the modern vaporisers (Pottie, Dart, and Perkins 
2008). Isoflurane is non-flammable, highly stable and has low blood 
solubility. Post procedure, it is known that this has very little 
biodegradation. Smooth induction followed by rapid recoveries were 
noticeable in early clinical trials (Ball and Westhorpe 2007). Low blood 
solubility is an important factor ensuring rapid induction of general 
anaesthesia. Isoflurane has a blood gas partition coefficient of 1:46 which 
when compared to halothane which has a blood-gas partition coefficient 
of 2.54. Decreasing blood solubility leads to rapid induction of 
anaesthesia which is crucial for a satisfactory postoperative recovery. 
Premedication and choice of drugs such as the intravenous anaesthetics 
may also impact on both the use of inhalation agents and the quality of 
recovery.  
 
One study suggested that the use of sevoflurane with a more pleasant 
odour improves the patient tolerance compared to isoflurane with a more 
pungent odour. This could be a factor with tolerance of mask inductions 
(Wallin et al. 1975). Cats tend to be fractious in nature, and sevoflurane 
is ideal due to its rapid inhalation induction and induces less ‘breath 
holding’ compared to isoflurane. Sevoflurane is also ideal in 
circumstances where a rapid change in the plane of anaesthesia is 
required. Sevoflurane has shown to have no recovery issues in patients 
that have liver or kidney disease (Tzannes et al. 2000). One of the key 
factors of the slow uptake in the use of sevoflurane is cost, this could be 
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offset when hidden factors such as monitoring time postoperatively are 
considered. (Tzannes et al. 2000). Mask induction without IV access 
being secured may reduce personnel time. 
 
Respiratory depression occurs commonly in both sevoflurane and 
isoflurane anaesthesia. Cardiac output is slightly reduced at light planes 
of anaesthesia and muscle relaxation is excellent. It was stated that 
diastolic function is conserved during isoflurane and sevoflurane 
anaesthesia when compared to halothane (Pottie, Dart, and Perkins 
2008). 
 
In a review undertaken by Shaughnessy and Hofmeister (2014) in which 
findings were collated from 17 studies of isoflurane and sevoflurane, 3 of 
these studies showed that the MAC value for isoflurane ranged from 
1.2% to 2.22% and that of sevoflurane between 2.5% to 3.95% 
(Shaughnessy and Hofmeister 2014). The same review showed that 
MAC values could potentially be affected by age of patients which could 
be a crucial factor in early neutering of cats (Shaughnessy and 
Hofmeister 2014). 
 
A study reviewing the speed of mask induction using sevoflurane and 
isoflurane for comparison have shown that sevoflurane was quicker to 
successful intubation compared to isoflurane despite both having ideal 




Surgical anaesthesia is usually achieved at 1.5 times MAC which shows 
that a higher vaporiser setting is likely to be required for sevoflurane in 
comparison to that of isoflurane to ensure adequate depth of 
anaesthesia. MAC is also reduced however by premedication and 
therefore vaporiser settings will be dependent on many factors (Raue et 
al. 2019). 
 
2.5 b, Endotracheal intubation 
 
Endotracheal intubation is a common procedure in veterinary 
anaesthesia, yet it is not without risks and may contribute to perioperative 
mortality in feline patients (Hofmeister et al. 2007). A study in 2007 found 
63% of deaths postoperatively occurred in cats that were intubated 
compared to 48% that were not intubated. This suggests that tracheal 
trauma maybe a contributing factor rather than airway obstruction per se 
(Brodbelt et al. 2007). The study was based on a range of cases from 
117 veterinary centres across the UK and covered all American Society 
of Anesthesiologists (ASA) status levels from I - V. The study did go on 
to state that increasing ASA physical states by one category was 
associated with a threefold increase in odds of deaths hence the 
importance of a defined category for patients. The overall risk of 
anaesthetic and sedation related deaths was 0.24%. Furthermore, the 
study suggests that endotracheal intubation should be used with caution 
especially for minor procedures; it may be more appropriate to provide 
oxygen without an endotracheal tube. Notwithstanding this finding, it was 
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acknowledged that endotracheal tubes have a role in complex 
procedures where maintaining an airway is paramount (Brodbelt et al. 
2007). A significant concern in the feline patient is their airway anatomy, 
having a much smaller and delicate trachea compared to that of the dog. 
Cases of tracheal injuries lead to claims against the veterinary surgeon 
(Adshead 2011). The Veterinary Defence Society (a mutual insurance 
company insuring veterinary surgeons and registered veterinary nurses) 
typically deal with 1-3 tracheal injury claims following endotracheal 
intubation each year (Hird, 2019). 
 
The function of the endotracheal tube is to deliver carrier gases and 
volatile agents to and from the breathing system to the patient. 
Capnography, which should be an essential part of routine anaesthetic 
monitoring, can help confirm correct placement of an endotracheal tube 
(Bilbrough 2006). However, the use of capnography in veterinary practice 
may be as low as 10% which could contribute to poor patient safety 
(Brodbelt et al. 2007). 
 
The use of cuffed endotracheal tubes rather than uncuffed tubes remains 
controversial and various papers have documented the resulting injuries 
(Mitchell et al. 2000, Hofmeister et al. 2007). There are some advantages 
to cuffed tubes which includes delivery of inhaled anaesthetic gases with 
an airtight seal. The prevention of environmental contamination (Weber 
et al. 2009) is a crucial factor in health and safety. Other factors include 
prevention of aspiration of fluid commonly associated with dental 
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procedures, accurate measurements and readout of capnography and 
reduction in expenditure on medical gases and inhaled anaesthetic 
agents. 
 
One disadvantage is cuff over-inflation especially when over 3mls of air 
has been used to inflate the cuff (Wilson et al. 2016). This can cause a 
longitudinal tear between the trachealis muscle and tracheal rings 
(Adshead 2011). A study undertaken on cadavers demonstrated tracheal 
rupture in 70% of cases when >6mls of air was used to inflate the cuff. 
This over-inflation represents a significant risk for airway trauma (Hardie 
et al. 1999). Tissue necrosis as a result of large pressure over a small 
surface area of tracheal mucosa which would otherwise benefit from an 
evenly distributed pressure or more accurately measured pressure on a 
given surface area. 
 
Other studies using cuffed endotracheal tubes reported barotrauma from 
excessive inflow and not allowing excess gas to vent. This causes the 
patient's lungs to be distended and exposed to excessive pressures 
(Rezende 2018). Uncuffed tubes are more commonly used in feline 
patients primarily due to prevention of traumatic injuries through tracheal 
tears and damage. The main advantages of using such tubes are ease 
of placement, ease of visualisation of arytenoid cartilages of the larynx 
when placing tubes, and less likelihood of accidental removal during 
anaesthesia or movement of patients (Hofmeister et al. 2007). Uncuffed 
tubes come with their own faults, these being environmental 
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contamination with volatile agents because the seal around the tube is 
imperfect, leakage of material and liquid, especially during dental 
procedures which could cause aspiration pneumonia if not monitored. 
 
Simple methods could help to minimise iatrogenic tracheal trauma. For 
example, gaining sufficient experience in endotracheal placement and 
minimising movement of the patient both prior to and post placement. 
Technological advances are continuing to be made, in human practice 
and veterinary practice; handheld pressure gauges are used to ensure 
suitable measured inflation (Adshead 2011). These are products which 
are specifically designed to offer a digital readout of pressure when 
inflating cuffed tubes. Built-in manometers which should be used, fill the 
cuff to a pressure between 20-30cm H2O as recommended by 
manufacturer guidelines. Recent studies have shown that the lower end 
of the range: 20cm H2O, is considered to be safe for cats (Grubb 2019). 
Using this method offers a simple but effective means of accurately 
measuring pressure therefore removing potential risks to the patient.  
 
2.5 c, Use of Masks.  
 
Masks used for the induction of inhalation anaesthesia have been used 
in veterinary practice since the origins of its development (Mutoh et al. 
2001). In its design, it is non-invasive and a simple means of delivering 
gases and equally important for a method of ventilation should it become 
required. It is also an alternative to intravenous anaesthesia which may 
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be a safer approach especially in compromised patients or in small 
patients such as prepubertal cats undergoing neutering where venous 
access can be difficult.  
 
The volatile agent is usually delivered in oxygen (with or without nitrous 
oxide) through tight fitting masks which have evolved over time in terms 
of design (Lerche, Muir, and Grubb 2002). Most anaesthetic masks are 
transparent which have the added advantage of allowing visualisation of 
fogging, vomiting and any facial abnormalities that require detection. 
They are designed with a flexible silicone diaphragm which allows 
minimal air leakage during ventilation. Some designs have moulded 
integral connectors which allow attachment to breathing systems and 
also attachment to patients if this added security is required. They vary 
in size which is significant progress in development especially in terms 
of the internal volume of the mask which should be as small as possible 
in order to reduce dead space. In one study in paediatric patients the 
mask internal volume could be as much as 30% of their tidal volume 
which is a clear indication that suitable sizes for patients are necessary 
(Moyle, Davey, and Ward 1999). Additionally, suitable scavenged masks 
offer a clear advantage compared to the use of chamber induction in 
terms of environmental pollution (Steffey et al. 2015). 
 
Of the licenced volatile agents, sevoflurane’s profile offers the most 
favourable mask induction especially in human paediatric patients 
(Mutoh et al. 2001). 
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The comparison of the volatile agents with nitrous oxide for anaesthetic 
induction have shown that there is no difference in the induction time 
between isoflurane and sevoflurane (Hikasa et al. 1996, Tzannes et al. 
2000). It is known that without suitable premedication, mask induction 
alone offers a slower onset of induction and could potentially be 
associated with side effects such as excitement, excessive body 
movements, breath holding and struggling especially during the initial 
stages of the induction period (Mutoh et al. 2001). A study comparing 
mask induction of anaesthesia with isoflurane or sevoflurane in 
premedicated cats showed that sevoflurane offered a shorter time to 
intubation and induction of anaesthesia compared to isoflurane although 
it went on to state that mask induction quality was very similar between 
the two volatile agents (Lerche, Muir, and Grubb 2002). Face mask 
induction also aids quick placement of the endotracheal tube after the 
initial period of mask induction thereby allowing rapid control of 
ventilation and the ability to maintain a suitable plane of anaesthesia 
(Tzannes et al. 2000).  
 
2.6 Sedation scoring assessment systems 
 
The definition of sedation is a reduced response to an external stimulus. 
Examples of this could be verbal and physical stimuli (Simon and 
Steagall 2020). Profound sedation can be used instead of a general 




There are numerous sedation scoring systems which have both been 
developed and modified over the years (Reader et al. 2019, Ribas et al. 
2015). In some cases, studies have influenced and modified this midway 
depending on the observational behaviours seen. Good, careful use of 
sedation drugs has shown to decrease morbidity and mortality in patients 
which is invaluable (Waldmann 2010). It is documented that validation 
and reliability is key. Validation is important to ensure that each 
component has a margin of sensitivity in terms of scales which must have 
the ability to be reproduced for each case in order to ensure the reliability 
of the data obtained as evidence. The decision-based approach for the 
choice of sedation scoring should be based on familiarity, and ease of 
use which would allow the scale to be used in a consistent manner but 
also reproducibility to allow standardisation in the study. 
 
There are several types of scales commonly used: these being the simple 
descriptive scale (SDS), numeric rating scale (NRS) and visual analogue 
scale (VAS). Such scales have primarily been designed for the 
observational behaviour which relates to pain. Studies have modified 
these scales using the objective design of this to incorporate the validity 
and use in sedation scoring. 
 
The (SDS) is best defined as using simple expressions usually in the 
form of descending pattern which defines the score such as palpebral 
reflex in a descriptive form, i.e., 0 - brisk, 1 - slow, and 2 - absent. An 
example of this composite simple descriptive sedation score form is seen 
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in a study by Gurney et al (2009). This is modified from Kuusela et al 
(2000) (Gurney et al. 2009, Kuusela et al. 2000). The design covers 7 
key points which covers spontaneous posture with 0 for standing, 1, 
sternally recumbent and 2 for laterally recumbent as an example with an 
overall score of 0 - 15 with 0 = no sedation and 15 = well sedated. Other 
similar forms are noted in studies by Wagner et al which is derived from 
a sedation scale obtained from Grint et al  (Grint, Burford, and Dugdale 
2009, Wagner et al. 2017). Ribas et al (2014) uses a version which 
covers posture score, behaviour and muscle relaxation as part of the 
sedation scoring process (Ribas et al. 2015). This scoring method was 
later adapted in a study evaluating two different IM protocols on sedation, 
recovery and ease of venepuncture in cats undergoing blood donation. 
The study included elements such as reaction to injection (0 = none, 1 = 
mild, 2 = moderate, 3 = severe) (Reader, Barton, and Abelson 2019). 
 
The NRS uses an ascending numerical scale which is usually a scale of 
0–10. This leaves an open interpretation of what is observed or collected 
which could pose problems for validity unless the same personnel are 
used throughout the study. Having said this, it is noted that NRS can 
differentiate between minor variations of changes (Tranquilli, Grimm, and 
Lamont 2004). 
 
The VAS scale consists of a simple line usually 100mm long on which a 
cross is placed by the observer. The VAS is designed to offer a measured 
approach of severity (in mm) but errors can occur because the accuracy 
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is open to interpretation as to where one places the level of severity on 
the line (Holton et al. 1998). 
 
There are other scales which are used but not necessarily for sedation 
scoring. An example of this is variable rating scale (VRS). These usually 
take into account specific parameters such as heart rate and blood 
pressure, which is ideal for measurements of pain. This may cause a 
data dilemma in terms of incorporating this as there could be wide 
variations of information to assimilate.  
 
2.7 Recovery assessment systems 
 
The quality of the recovery is important especially in high throughput 
neutering programmes where time and resources may be limited to 
accommodate prolonged and poor-quality recoveries from anaesthesia. 
Pressure mats were first identified as useful to evaluate patients with 
orthopaedic conditions but could also be re-purposed to evaluate quality 
and nature of recovery from anaesthesia. One study showed pressure 
mats could accurately measure gait parameters in healthy cats during 
walking and jumping (Stadig and Bergh 2015). These may offer 
additional useful observations to studies that are particularly focused on 
speed and quality of recovery. Currently their cost precludes their use in 




Another method of measuring recovery is by using a cat portal. Burton's 
Cat Cube is designed to allow movement between two kennels adjoined 
by a portal (Figure 2). The door is vented and made from toughened 
glass to promote patient observations. The portal measures 24 inches 
wide x 30 inches high x 26.4 inches deep. It was originally designed to 
offer a compartment approach to merge two side by side kennels 
together to offer a larger surface area especially for those that may 
require a longer stay (Burtons Medical Ltd). These were originally 











3.0 Aims and hypotheses 
 
The aim of this research was to evaluate and compare two anaesthetic 
combinations designed to be used in welfare organisations for neutering 
programmes. Medetomidine and buprenorphine (MB) were compared to 
medetomidine and methadone (MM) for their suitability for orchidectomy 
anaesthesia in cats. The aim was to use a standardised protocol 
incorporating mask induction prior to maintaining anaesthesia. It was 
hypothesised that both combinations would provide a rapid recovery 
period to allow a high-volume turnaround in a charity setting. Additionally, 
it was hypothesised that MM would provide superior sedation and a 






The prospective study was undertaken during a weekly routine castration 
clinic at R.S.P.C.A Greater Manchester Animal Hospital between 
17/04/19 and 14/02/20. Cats presented to the ‘open clinic’ originated 
from five sources: veterinary triage, usually via the inspectorate, TNR / 
feral cats for population control, multi-cat household intervention, branch 
and lastly, owned cats. The study was designed to simulate a high 
volume setting in a mobile clinic which explores the feasibility of 
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employing an approved protocol for routine use. The study aimed to 
compare two anaesthesia combinations: - 
 
● Medetomidine 500mcg/m² and methadone 5mg/m² 
● Medetomidine 600mcg/m² and buprenorphine 180mcg/m² 
 
The protocols used were standardised between groups. The final 
selection of drugs for the study was determined after iterative work within 
the hospital during the months prior to study, the study design is outlined 
in Figure 3.  
 
Careful considerations were made on informed consent due to the 
differentiation of the sources listed, for example, vet triage animals 
usually brought in by the inspectorate. In this case, informed consent is 
already within the remit of the RSPCA ownership. This differs from owned 
animals where consent is gained via signed consent obtained on 
admittance. This is further analysed later in the conclusion. Despite 
varying sources, the protocol for the study remained the same for 
impartial outcomes avoiding biased and consistency, this is further 
enhanced by the use of the pilot study initially to explore the feasibility of 
the main study. 
 
The study was conducted in an environment where there was a blinded 
view taken to ensure data recording was not influenced through 
knowledge of type of combination used. The initial sedation assessment 
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through to the end assessment observations were conducted with the 
view that no knowledge of the combination was known and that the remit 
was on the supervising surgeon to ensure analgesia was prioritised and 
a secondary back up measure in the form of rescue anaesthesia was 
prepared in accordance to the responsibility of the veterinary surgeon 
under the Veterinary Surgeons Act 1966. 
 
The study was approved by the ethical review board, Nottingham 




Figure 3: - Flow chart outlining the decision-making processes 
involved in selecting the final protocol. The key principles such as 







A pilot study was undertaken using 15 cases presented to the clinic 
between 6/3/19 and 3/4/19 to evaluate the differences and design of the 
study.  
 
In total 166 feline cases were used for this study. Initial cases were used 
to refine both sedation scoring and recovery scoring methods to ensure 
accuracy and reliability. These were excluded from final data analysis to 
ensure accuracy and unform data collection. 
 
Further refinement was also carried out to include portal exploration 
times which offer an insight into quality and timing of recovery which was 
crucial to the study.  
 
All cats recruited were deemed healthy and classified as ASA I. A full 
clinical evaluation was undertaken prior to surgery and post recovery with 
the aid of Nottingham University final year veterinary students 
undertaking shelter medicine extramural rotations and in agreement with 
current RSPCA policy.  
 
4.3 Enrolment and inclusion  
 
One hundred and sixty-six healthy cats were recruited in total for the 
study including the initial trial and early development. Animals were 
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fasted for a minimum of 8 hours prior to anaesthesia; all were provided 
with water up until the point of intramuscular injection of the 
combinations. All animals were weighed. Consent from owned patients 
formulating part of the study data collection were obtained via 
incorporated consent declaration on anaesthetic / procedure consent 
forms on admittance. All data was collected including demographic 
information which were later analysed. 
 
4.4 Administration of drugs  
 
Premedication consisted of one of the two following combinations at the 
dose rate listed;  
 
Combination 1 - Medetomidine 600mcg/m² and buprenorphine 
180mcg/m² MB 
 
Combination 2 - Medetomidine 500mcg/m² and methadone 5mg/m² MM 
 
The products used were medetomidine (Sedator 10mg/ml; Dechra 
Veterinary products), methadone 10mg/ml, (Comfortan, Dechra 
Veterinary Products) and buprenorphine, Buprenodale 0.3mg/ml, Dechra 
Veterinary Products). 
 
The drugs were drawn up by veterinary students of Nottingham 
Veterinary School and checked and supervised by an approved teaching 
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supervisor (Veterinary Surgeon). Both drug combinations were 
administered by students into the quadriceps femoris. Ten minutes 





The data collection from sedation scoring, anaesthesia, visual 
observations and recovery were undertaken by the same assessor, who 
was an experienced registered veterinary nurse.  
 
All procedures were timed and assessment timepoints standardised 
between groups.  
 
Simple descriptive scale for sedation 
 
Sedation was scored using a modified SDS extending to include how well 
the mask was tolerated by the patient. The scale consisted of 7 key 
components with a total score of 18 possible. 
 
Table 1: - Simple descriptive scale for sedation adapted from Gurney et 
al (2000). 
 
Criteria Score  Score 





























































































4.6 Anaesthesia Protocol 
 
Ten minutes after sedation scoring, animals were transported from the 
preparatory area to the main theatre. Anaesthesia was induced via a 
tight-fitting face mask connected to the Mapleson F system using 2% 
isoflurane (Isoflo, Pfizer) in 100% oxygen for a period of two minutes. 
During induction of anaesthesia a cuffed endotracheal tube (Portex) was 
measured and cut to appropriate length for the patient. At the end of the 
two minutes of induction, the face mask was removed, the breathing 
system temporarily plugged to prevent environmental contamination, and 
the cat's larynx was sprayed with lidocaine (Intubeaze, Dechra). Mask 
induction continued for a further minute and the endotracheal tube was 
then placed. Anaesthesia was maintained using 1% isoflurane in 2 litres 
of oxygen. The cuff of the endotracheal tube was inflated using a cuff 
inflator and manometer (AG Cuffill™) to 30 cm H2O pressure to prevent 
tracheal rupture or injury and facilitated an improved monitoring 
approach using capnography.  
 
Meloxicam (Metacam, Boehringer Ingelheim) was administered prior to 
surgery via the subcutaneous route after the induction of anaesthesia at 
a dose rate of 0.3mg/kg.  
 










4.7 Physiological parameters 
 
Anaesthesia was continuously monitored by a designated person and 
parameters were recorded at 5-minute intervals. Throughout this study, 
heart and respiration rate was auscultated. Capnography was used in all 
patients to ensure accuracy of endotracheal placement and monitoring 
CO2 during anaesthesia throughout. Capnography was undertaken using 
a portable model (Capnoeasy™ Burtons Medical Ltd) which measured 
end-tidal carbon dioxide and respiration rate. A pulse oximeter (Burton's 
medical unit) was also used and measured heart rate (HR), and arterial 
haemoglobin saturation with oxygen (SpO2%). 
 
4.8 Anaesthesia maintenance 
 
Anaesthesia was maintained with 1% isoflurane in oxygen. Vital signs 
prior to administration of drugs were conducted for baseline recording. 
Anaesthetic monitoring occurred throughout the procedures. Muscle 
tone was monitored along with jaw-tone and palpebral reflexes until the 
placement of a cuffed endotracheal tube. The Cuffill™ (manometer) was 
used to fill endotracheal cuffs to the desired inflation to prevent any 
tracheal trauma. All surgeries were undertaken by veterinary students 
and anaesthesia was monitored by a second veterinary student. The 
procedure was under constant supervision by qualified approved 
veterinary surgeons throughout. Isoflurane was discontinued at the end 














4.9 Atipamezole and recovery management 
 
Atipamezole was administered IM one-minute post completion of surgery 
at a dose equivalent to half the volume of medetomidine. Isoflurane was 
discontinued, but oxygen was administered for a further minute. The 
endotracheal tube cuff was deflated, and the cat’s trachea was extubated 
prior to the cat being placed in lateral recumbency in the right side of a 
Cat Portal system. Recovery was timed. Time taken to sternal 
recumbency and to completely enter the left-hand side of the portal 
accommodation via the portal were recorded (Figure 5). There was a litter 
tray and a small, standardised portion of Hills a-d food in the left-hand 
side of the portal.  
 
4.10 Adverse events 
 
Adverse events were also recorded as free text on the anaesthetic 
monitoring chart.  
     
     












5.0a, Demographic data 
 
Complete data sets for 92 cats were collected. There were 56 cats in the 
medetomidine and buprenorphine (MB) group and 33 cats in the 
medetomidine and methadone (MM) group. Those initially excluded 
based on having no portal times were included in the final analysis. Portal 
times were later added after initial trial to improve accuracy of numerical 
data results for the recovery stage. 
 
The demographics of cats used in the study showed that more cats were 
public owned in the MM group (58%) compared to the MB group (36%). 
There were more neuters of cats from branch practices in the MB group 
(30%) compared to the MM group (12%). There were marginally more 
seen from Vet Triage (VT) sources in MB group (33%) in comparison to 
that of MM (30%).  
 










Table 2: - Weight of patients and surgery times  
 
Group MB (N=56) MM (N=33) P value 
Surgery duration 
(Mins) 
13 ± 7.9 15 ± 5.5 0.12 
Weight (kg) 2.6 ± 1.2 2.7 ± 1.1 0.38 






Demographics of animals undergoing castration and duration of surgery. 
Data are presented as mean ± standard deviation or median (range). 
Significance tested using Student’s t test which the confidence interal (CI 





































5.0b, Sedation  
 
The mean sedation score which included the tolerance to mask induction 
for the two groups is shown in table 3. The mean scores in the MM group 
were significantly higher compared to cats in the MB group (p < 0.02, 
Student T test).  
 
Table 3: - The sedation quality between two combinations using a 
modified SDS (Simple Descriptive Score) 
 




12 ± 2.8 13 ± 2.9 0.024 
 
Data are presented as mean ± standard deviation. Significance tested 





Intraoperative variables for heart rate and respiration were collected at 
5-minute time points up to a maximum time point of 30 minutes. 
Physiological variables remained within clinically acceptable limits. HR 
(Figure 7) showed an increase over 10 minutes time point which 
coincided with mid-surgery. This data also suggests an increase in HR 
levels towards the postoperative stage. MM also showed a decrease in 
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both RR but HR showed a return to initial HR measurements throughout 
the procedure showing sufficient depth of anaesthesia and stabilisation 
for the postoperative stage.  
 
Table 4: - HR data collated for the duration of the surgical procedure for 
both combinations. 
 































Heart rate data recorded over a minute period and obtained in 5-minute 
intervals throughout the duration of the surgery for the two combinations 
(MM and MB). Data are presented as mean ± standard deviation. 
 
Data were obtained during the average monitoring period, which showed 
that MB was marginally longer in time than MM hence, no data obtained 









Table 5 - RR data collated for the duration of the surgical procedure for 
both combinations. 
 
















Respiratory rate data recorded over a minute period and obtained in 5-
minute intervals throughout the duration of the surgery for the two 
combinations (MM and MB). Data are presented as mean ± standard 
deviation. 
 
Data were obtained during the average monitoring period, which showed 
that MB was marginally longer in time than MM hence, no data obtained 
at the 30 minute interval. 
 
 
5.0d, - Recovery 
 
The times to gain sternal recumbency and to fully enter the adjacent side 
of the cat portal were recorded from the time of the atipamezole injection. 
Both times were significantly quicker to sternal (p < 0.002; Student’s t 
test) and entering portal (p < 0.002; Student’s t test) for the MM group 





Table 6: - The mean times for recovery (minutes) 
 
 MB (n=56) MM (n=33) t-test p value 
Time to sternal 
(minutes) 
7.3 + 3.6 4.9 + 3.6 0.002 
Time to enter 
the portal.  
(minutes) 
9.8 + 5.9 6.4 + 4.0 0.002 
 
Data are presented as mean ± standard deviation. 
 
MB Medetomidine and Buprenorphine, MM Medetomidine, Methadone 
 
5.0e, - Adverse effects 
 
The adverse effects were low although isoflurane vaporiser settings had 
to be increased for MB in 10 cases (18%). Mask resistance was noted 
for 4 cases (7%) in the MB group. There were no significant differences 
between groups for vomiting during the initial sedation stage (Table 7).  
 
Table 7: - Adverse effects observed  
 
Adverse reaction MB (n=56) MM (n=33) 










Data are numbers of cats exhibiting adverse events. MB Medetomidine 




This is a unique study which explored a novel anaesthetic approach for 
a high throughout charity establishment with a strong focus on neutering 
with very little resource. 
 
It was hypothesised that the combination of medetomidine and 
methadone would be superior for induction, and recovery resulting in a 
quick turnaround for high volume neutering. 
 
It is furthermore acknowledged the huge progress made previously with 
the Quad combination and licensed Triple. The purpose was to devise 
an anaesthetic protocol suitable for mass neutering programmes building 
on the previous work (Yates and Leedham 2019, Joyce and Yates 2011). 
A careful approach with the novel aim of having welfare at the forefront 
was taken. With anaesthetic requirements in mind, the principle was to 
facilitate a high throughput of cats, neutered in situ using a purpose-built 
mobile theatre. Significant benefits are to those in the community where 
travel is an issue and to undertake outreach work in multi-cat 
environments where up to 20 neuters is possible. One study showed that 
in 10 households identified as a public complaint associated with 
hoarding behaviour reported to the RSPCA intervention team, there were 
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176 cats, a median of 16 cats per household which showed the huge 
scale of the problem (Hill et al. 2019).  
 
A short acting anaesthetic with a fast recovery to allow both quick returns 
to owners and a rapid cost-effective turnover of neuters was required. 
This builds on studies that have shown that stress associated from 
unfamiliar surroundings can be considered to negatively impact on 
welfare, hence the reason to explore short acting protocols for quick 
recoveries (Wongsaengchan and McKeegan 2019). Furthermore, the IM 
route for initial induction of anaesthesia rather than intravenous route 
was also important and necessary. The primary outcome was a reliable 
dosing schedule to ensure personnel ease of use for accurate, quick 
calculations and safe anaesthesia. 
 
It is difficult to differentiate between the MM and MB combinations in 
terms of analgesia, primarily due to the severity of the pain challenge of 
each procedure and the combination of analgesic drugs used. The 
surgical skills and competency of the students vary resulting in different 
lengths of procedure as a result of the learning process, however this is 
a realistic environment which utilises resources in a high-volume 
veterinary practice. The protocol used in this study had a crucial element 
of assessing the sedation quality. This factor is rarely captured in 
mortality and morbidity studies (Simon and Steagall 2020) so 
establishing the metric is an advancement. This is an important factor 
when validating a combination. The difficulties with such research is that 
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when individual pharmaceutical components are combined it is rather 
difficult to parse out the factors individually. This supports the notion of 
sedation scoring, to establish initial differences too at the start of the 
procedure, rather than only focussing on outcome measures at the end 
of the procedure. However further studies would still be useful to 
compare the differences between different combinations as a whole from 
staff and owner perspectives (Matthews et al. 2017). 
 
The recovery times is an essential purpose of the study to allow a 
sufficient turnaround in quantity of patients in an given environment. This 
study concludes that both combinations offer a viable option in regards 
to reducing recovery times compared to the availability of anaesthesia 
combinations currently available (Bruniges, et al 2016). However it must 
be noted, there are literatures and studies which explores different 
durations of recovery of patients with potential to look at other opioids 
available such as butorphanol (Moser et al, 2020). There are different 
opioids at different strengths which have potential to improve on recovery 
outcomes in terms of timings and quality compared to others widely 
available through further research (Ko et al 2011, Bruniges et al, 2016 
and Mahdmina et al 2020). 
 
Intramuscular combinations are crucial in high volume charity practice as 
this offers ease of approach for administration. Other advantages are 
quick preparation of equal dosing protocols, reliability in small patients, 
non-incremental dosing which reduces implications of errors. Utilising 
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veterinary nurses for administration of non-incremental dosing which 
they would normally be prevented from carrying out would be of benefit 
to a reduced staffing environment. Cost factors of drugs when using 
larger doses in larger patients comparable to that of linear dosing are 
also crucial to ensure sustainability in use.  
 
In retrospect; there are some disadvantages of the IM approach, these 
being no IV access for intubation difficulties, post mask placement 
difficulties and other potential emergencies during surgery. Previous 
research carried out on small cats showed that IV combinations using 
alfaxalone are effective, but ease of access and placement is 
challenging, and dependent upon staff expertise (O’Hagan et al. 2012, 
Zaki, Ticehurst, and Miyaki 2009). 
 
The limitations of the mask inductions were apparent with two key 
factors, firstly the MB combination had a lower sedation score as 
originally hypothesised, and upon mask induction there was some 
resistance which then posed difficulties for intubation. Secondly the other 
factor was the use of feral cats. Feral cats in a shelter veterinary 
environment are prevalent as part of the approach to population control, 
hence the need to ensure that combinations can accommodate this. The 
IM approach is useful and far safer for staff and these patients, although 
these cats were less sedate for mask placement. There are 
considerations as to whether ketamine as an additional component 
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would prove useful. This would be a natural progression to extend a study 
to include a contingency factor.  
 
The use of ketamine in one study was found to offer cardiovascular 
stability during undertaking echocardiographic examinations (Lazzarini 
et al. 2020). Further research evaluating for example a dose of 1mg/kg 
of ketamine and the effects on cardiovascular involvement would be 
beneficial as no studies incorporating it are known in cats (Slingsby and 
Waterman-Pearson 2000). The benefits of this could prove useful 
especially in fractious cats or feral cats for neutering purposes. The 
progression could offer an alternative to the risks posed with mask 
inductions but in retrospect the current study using the IM route for ease 
of access, rapid and reliable sedation and profound analgesic effects is 
highly attractive for high throughput neutering. A study to explore the 
timings of ketamine administration in a high-volume setting is warranted. 
 
The physiological effects of the alpha 2 agonist such as medetomidine 
which is used in both combinations in the study is a factor to consider. It 
is documented that optimum sedation can only be achieved in calm and 
quiet surroundings with little environmental stimuli. Evidence has shown 
that pre-existing fear, pain, excitement, stress and even aggression such 
as in the case of feral cats may delay the onset of sedation (Sinclair 
2003). In a high-volume setting noises such as personnel walking past 
kennels or cleaning in kennel areas which may disturb recoveries is 
difficult to control for. However, this represents a normal hospital setting 
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so the results from the sedation and recovery scores despite these 
concerns accurately reflects clinical practice. The degree of 
environmental noise is recorded in some studies (White and Yates 2017). 
The addition of the opioid ensures more profound sedation (Slingsby et 
al. 2015).  
 
The use of medetomidine was used in both combinations, further studies 
could be undertaken using dexmedetomidine. Studies have shown this 
to have a shorter duration of onset of around 5 minutes (Simon and 
Steagall 2020, Reader et al, 2019) which could prove useful for a quicker 
onset of sedation or if there is an improvement on the sedation scoring 
used in this study. The same study has shown this combination to have 
superior analgesic effects and antinociceptive effects were improved 
when this combination was used (Simon and Steagall 2020). Further 
research in this area could see potential improvements in sedation using 
the same protocol of mask inductions.  
 
The duration of surgery with these combinations also has room for further 
research. The focal point of this study was cat castrations which had an 
average surgery time of 30 minutes in duration. The question posed is 
the suitability of the combination for cat spays which inevitably increases 
surgery time. Earlier studies have shown suitability of the extended 
period of analgesic effects and this could potentially apply to other 




Thermoregulation is a crucial factor because of the effects of alpha 2 
agonists and the importance of maintaining temperature during and after 
procedures.  Research into recovery timings in relation to environmental 
temperatures such as comparisons to heated and non-heated 
accommodation for recovery stages would be beneficial. The risk of 
hypothermia is a factor to consider especially with patients with high body 
surface area to mass ratio where delays of recovery could be detrimental 
(Clancy 2016). 
 
Sedation scoring at 10 minutes post injection of the combination was 
calculated for its effectiveness in this study. This could be expanded to 
include intervals as early as potentially 5 minutes, 10 minutes and also 
15 minutes prior to mask induction. This could give a reliable insight to 
see if there were any changes in the quality of sedation. Further research 
could see the optimum time using different time points for quality and 
onset of sedation prior to surgery.  
 
The implications of using inhalation anaesthetics were considered in the 
study design due to environmental concerns usually associated with 
chamber or mask inductions. The study had a strong emphasis on safety 
but equally factoring in the effectiveness of the combination. Chronic 
exposures of personnel to anaesthetic gas can cause oxidative stress, 
DNA damage and carcinogenesis which is a significant concern 
especially those working as anaesthesiologists (Fay 2018). Equipment 
to minimise the effects of this such as scavenging systems and waste 
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control systems such as ventilation systems / air conditioning can reduce 
these but not eliminate the waste gas in total. The thresholds for 
monitoring waste gas do vary from country to country which governs 
permissible limits, an example is 50ppm (parts per million) (383mg/m3) 
in England comparable to 5ppm (38mg/m3) in Denmark (Deng et al. 
2018). The use of Salus monitoring devices were used in this study to 
compare differences between normal working environments compared 
to the use of mask inductions in this study. Salus monitoring devices are 
designed as badges worn in the clinical environment which measures 
exposures within a given specified time on an 8 hour time weighted 
average. This ensures that the limits are within the work exposure limits 
(WEL). These are usually advised to be performed 6 monthly or annually 
(by the HSE and the RCVS Practice Standards Scheme). The results 
were that there were no increased levels using either mask inductions 
combinations in a duration of 6 hours. There were three personnel 
involved during the duration of the monitoring process with results of 2.2 
ppm, 2.7 ppm and 2.4 ppm which were all well below the levels of 
maximum limits of 50 ppm and even below the lower levels of limits set 
by Denmark for comparison. The mask induction process in the 
combination formed a small step in the process (two-minute process of 
mask induction followed by a further one minute in between lidocaine 
administration over the larynx). A circuit cap was used to seal the end of 
the breathing system during each step to prevent unnecessary leakage. 
The mask induction was a key element prior to endotracheal intubation 
to smooth transition to the maintenance phase. It is known that excessive 
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concentrations to achieve sedation and involuntary excitement have an 
increased risk of mortality (Simon and Steagall 2020). Further studies 
could be undertaken on anaesthetic masks design and also whether 
there could be better designed breathing circuits. 
 
The use of cuffed endotracheal tubes in this study with a measured 
approach to the inflation of the cuff using a manometer cuffill™ syringe. 
The cuffill™ is widely used in human medicine given the controversial 
evidence of the use of cuffed endotracheal tubes in relation to tracheal 
trauma. It is reasonable to suggest that there is no reason why a careful 
approach could be taken to achieve a seal around the ET tube to ensure 
suitable maintenance following the initial mask induction. The tube was 
inflated to 30cm H₂O pressure in accordance with manufacturer 
guidelines and publications (Grubb, 2019, White et al. 2017). This was 
furthermore backed up with the use of capnography to aid suitable 
placement but equally avoiding both under inflation causing leakage of 
volatile gas and also over inflation which is a well-documented concern 
in veterinary use in cats. Although this study, and others shows that it is 
reasonable to use cuffed endotracheal tubes in cats, further research into 
lengths of tubes and the design of ET tubes are warranted. All too often 
an estimate of the tube in order to cut to size poses issues with the 
replacement of connectors allowing a smooth connection to the circuit.  
 
The data obtained during the monitoring process for HR and RR levels, 
It is noted, that average thresholds through all intraoperative variables 
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are markedly different with HR and RR levels recorded at all time points 
lower with MM than that of MB. Results are consistent with opioid 
together with alpha-2 agonists working synergistically due to posts-
receptors mechanisms being shared. Methadone compared to 
buprenorphine clearly showed that sedative and analgesic effects are 
more profound in methadone than seen in buprenorphine. This is also 
seen in a similar study by (Mahdmina et al. 2020). 
 
The process of recovery is scrutinised in this study of a high-volume 
neutering setting. There are risk factors that need to be considered since 
the recovery period is associated with more problems than the sedation 
and maintenance phases. It is stated in one study that the prevalence of 
mortality is 52-60% during the 3 hours postoperatively (Brodbelt et al, 
2007). This is one factor that was accounted for to reduce these risks by 
having a quick recovery process lasting minutes rather than hours. This 
helps nursing staff in a reduced staffed resource shelter environment to 
observe a recovery period before discharging which otherwise could 
stretch personnel time beyond the capacity to deal with a high volume 
intake (Brodbelt et al. 2007, Matthews et al. 2017). 
 
The recovery period duration is important, but the quality of the recovery 
still needs to be described too. Future studies could for example include 
ataxia, mobility, spatial awareness, ocular differences and other factors 
such as interest in food and time to eating. There are a huge range of 
parameters which could be explored with further research. Pressure 
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mats would offer a reliable gait analysis of cats however most research 
has been done involving either dogs or those with orthopaedic conditions 
(Stadig and Bergh 2015). Very little research has been done using 
healthy cats which could prove useful in a study such as this (Lascelles 
et al. 2007). Weight distribution, step cycles, jump analysis could all be 
developed using the pressure mat system originally designed to assist 
with diagnosis of orthopaedic conditions for qualities of recoveries. The 
limitations with the use of pressure mats are the complex technology 
needed which in turns has cost implications but nevertheless could prove 
useful with data obtained. This study used parameters including sternal 
times and portal entry times as key time points, it was felt that these were 
clear observational outcomes. Standing times are controversial as found 
by previous studies; for example a cat may stand on its front two paws 
but could appear as sitting down, so this may offer a flawed timed result 
(Bruniges et al. 2016). Entering the portal gives a clear indication that the 
patient would almost certainly would have to stand on all limbs to be able 
to walk and enter the portal giving a reliable insight to the quality of both 
mobility but also the recovery process. 
 
The data obtained for the age of each patient were obtained on records 
prior to admission, it is noted that these are estimated by non-veterinary 
personnel especially from sources such as the inspectorate, branches 
and those from large multi-cat households. These account for 64.3% of 




The demographic data which were obtained showed that VT work is a 
key component seen in charity practice. This is usually derived from 
inspectorate generated sources including those from multi-cat 
households, strays and ferals, and those participating in TNR work. It is 
important to note that VT sources are likely to have estimated ages on 
presentation. 
 
Vomiting is an effect of both opioids and alpha-2 agonists and is 
documented in some papers. It was an occurrence in this study primarily 
in cats from unknown sources. In these cats it is difficult to ascertain if 
and when the cat has eaten prior to surgery. This can be minimised as 
much as possible through recommended fasting before the surgery. 
There have been some studies undertaken to trial potent antiemetic 
medication such as maropitant which has been shown to reduce the 
incident of emesis in dogs and shown to be effective in cats if 
administered orally prior to sedation (Martin-Flores et al. 2017). 
 
The use of eating as an indicator of recovery was considered in the early 
stages of the pilot but it was argued that it was open to interpretation of 
findings and that it varied between cats. There are documented uses in 
trials using eating times as a factor of the recovery process especially 
when ketamine is used which evidently prolongs the recovery process. 
Anaesthetic agents and adjunctive drugs are known to stimulate appetite. 
This is worth considering if using such drugs as part of the protocol 
(Armstrong et al. 2018). The same study stated that the length of surgery 
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time could potentially affect the time to eating if measured post-
operatively. This is a factor that could prove useful if further studies are 
performed using feline ovariohysterectomy which tend to be a longer 
surgery time than orchidectomy. Overall, the standardisation of the study 
did entail a small proportional of Hills a-d (¼ of tin) which was placed in 
at the time of recovery for post-op welfare.   
 
Emesis is often reported with alpha 2 agonists due to stimulation of the 
chemoreceptors. In retrospect the cause of emesis in two cases in both 
combinations could also be a result of inadequate fasting times prior to 
admittance from owners or unknown due to mass neutering in multi-cat 
households. 
 
7.0 Further work 
 
The ability to reduce anxiety and calm animals prior to anaesthesia is 
desirable. The use of gabapentin could prove useful in future studies. 
Gabapentin is an antiepileptic which is available in tablet or liquid form 
which could be given by the pet’s owner. Documented evidence suggests 
that 100-150mg oral gabapentin could prove useful in reducing stress 
and may improve compliance with mask inductions if administered 90 
minutes before transportation in a carrier (Van Haaften et al. 2017). 
 
There is further research required on dose rates and routes of 
administration of other drugs such as low dose ketamine which has been 
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documented in dogs but not cats, this could be useful to reinforce 
protocols suitable for early neutering (Slingsby and Waterman-Pearson 
2000). 
 
The use of xenon as a novel gas instead of isoflurane has shown to have 
potential in some studies although notable rare and expensive but has 
shown to have no toxicity or teratogenic effects. The benefits would be 
rapid induction and quick recoveries through low blood solubility and 
minimal metabolism in the body (Lane et al. 1980). There are also cost 
implications and environmental concerns for production of this so careful 
consideration if these were brought into use (Neice and Zornow 2016). 
 
One study using methadone in combination with medetomidine as a 
premedication prior to ovariohysterectomy and castration in the cat by 
Slingsby et al (2015), acknowledged reliable sedation, however it went 
on to state that butorphanol could prove a useful component combined 
with medetomidine to provide a better level of sedation compared to 
buprenorphine. The study acknowledged there was no data to support 
this claim. Given the duration of butorphanol is 2 hours in comparison to 
that of longer durations of methadone and buprenorphine it could be a 
useful contender for short procedures such as castrations. However, it 
might be limited to castrations rather than ovariohysterectomy which 
have a longer duration of surgery and more intense nociception (Slingsby 




It is hoped that the findings from this study will improve anaesthetic 
protocols particularly in relation to the recoveries. The study will aid the 
primary objective of improving neutering of cats in a variety of scenarios 
such as public generated, feral cat population management and multi-cat 
household management. Use of face masks are well documented, but 
not widely accepted and research in design for those suitable for 
brachycephalic cats is needed, aiming for a good seal and reduced dead 
space to provide better induction but also reduced environmental 
contamination (Friembichler et al. 2011). 
 
 8.0 Conclusion 
 
Our studies have shown that the use of MM offered a superior multimodal 
approach using mask induction when compared to MB. As the 
hypothesis suggests, MM offered a higher sedation score compared to 
the buprenorphine combination although both appear to have quick 
recovery time overall when compared to other combinations such as the 
Triple and Quad combination. The modified scoring system which 
includes the mask induction assessment proves that this protocol 
enables a smooth process in which maintenance can take place through 
placement of an ET tube using a standardised process. It is concluded 
that MM is valid as a combination suitable for orchidectomy in cats and 




The speed of recovery crucial for a high turnaround in a high volume 
setting also showed that MM cats were quicker in their sternal and portal 
times compared to MB. 
 
It is important to note that atipamezole as a reversal agent had an 
important role in this study. There is research to be undertaken on effects 
of atipamezole in terms of dose rate and timings of administration which 
could prove useful to the hypothesis and strengthen the combination 
through a wide standardisation as a suitable combination for early 
neutering. 
 
The adverse effects of MB were markedly different to MM when 
considering the use of initial mask induction. In the MB group 10 cases 
needed the vaporiser increased which is 18% of total cases compared to 
2 cases with MM (6%). This was crucial data to collect to back up 
evidence of not only a more reliable method of induction but also 
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10.0 Appendix 
Appendix 10.0 - Architect specification for mobile theatre 
The specifications and design were done in conjunction with Botts Ltd. 
Designed as requested by Albert Holgate and Ben Faulkner. This vehicle 
was designed as a multipurpose operating theatre which can attend 
community outreach programmes, multi-cat households and branches 
which don’t have facilities to provide for veterinary support. The vehicle 
is designed to have its own power source and ability to be hooked up to 
external power. The vehicle has its own water supply and wastewater 
tank and heating supply. (See appendix diagrams which show the layout 






10.0a, Nearside Rear Specification – this highlights the typical layout with 
a focal point of 6 heated kennels. 
 
 









10.0b, Front Surgery Specification – This shows the layout of the 
operating area with enough room for 2 personnel (Veterinary surgeon 
and nursing support) 
 
 











10.0c, Front Surgery Specification – This shows a viewpoint of 
anaesthetic machine, operating table but with a focal point of a extension 
of design of whiteboard intended for student teaching support for those 
assisting veterinary surgeons during outreach work. 
 
 
Design plans by Bott Ltd (2018) 
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